Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,862,222
-
Total 13F shares
-
1,267,947
-
Share change
-
+1,267,947
-
Total reported value
-
$3,838,114
-
Price per share
-
$3.02
-
Number of holders
-
11
-
Value change
-
+$3,838,114
-
Number of buys
-
11
Institutional Holders of Benitec Biopharma Inc. - Common Stock (BNTC) as of Q3 2023
As of 30 Sep 2023,
Benitec Biopharma Inc. - Common Stock (BNTC) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,267,947 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, SUVRETTA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), RHUMBLINE ADVISERS, UBS Group AG, and GROUP ONE TRADING, L.P..
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.